Cocrystal Pharma, Inc.
COCP
$1.49
-$0.06-3.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.85M | -17.50M | -18.70M | -17.93M | -16.75M |
| Total Depreciation and Amortization | 103.00K | 126.00K | 138.00K | 231.00K | 208.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 636.00K | 753.00K | 816.00K | 664.00K | 678.00K |
| Change in Net Operating Assets | 189.00K | 140.00K | 1.10M | 2.82M | -193.00K |
| Cash from Operations | -14.92M | -16.49M | -16.65M | -14.21M | -16.06M |
| Capital Expenditure | 0.00 | -8.00K | -67.00K | -67.00K | -81.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -8.00K | -67.00K | -67.00K | -81.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 4.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 0.00 | 0.00 | 4.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.92M | -16.49M | -16.72M | -14.28M | -12.14M |